Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maternal breast milk is a complex biological fluid produced by the mammary glands of human mothers, primarily intended for infant nutrition but also investigated for therapeutic topical applications. It contains a rich array of bioactive substances, including secretory immunoglobulin A (sIgA), lactoferrin, lysozyme, and epidermal growth factor (EGF), which collectively exert antimicrobial, anti-inflammatory, and wound-healing effects. In clinical research led by the University of Malaya, topical application of maternal breast milk is being evaluated as a cost-effective and safe alternative to commercial barrier creams for the management of mild-to-moderate diaper dermatitis in infants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on maternal breast milk.